Prevalence of Transthyretin Cardiac Amyloidosis in Clinically Significant Aortic Stenosis

Clinical trial NCT04899180 · COMPLETED

Trial details

NCT number: NCT04899180
Sponsor: Mayo Clinic
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Aortic Stenosis Transthyretin Amyloidosis Transthyretin Amyloid Cardiomyopathy Transthyretin Cardiac Amyloidosis

Start date: 2023-07-14
Primary completion: 2024-01-05
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.